Click Diagnostics
Menlo Park, US · Founded 2012 · Delaware corporation · 1 known investors
Find your way into Click Diagnostics
Sign up to see every warm intro you have to Click Diagnostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Click Diagnostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Click Diagnostics offers the Visby device, an at-home PCR test that delivers results in about 30 minutes for common curable STIs including chlamydia, gonorrhea, and trichomoniasis. It connects users with licensed providers who can prescribe treatment upon a positive result, aimed at consumers managing their sexual health without visiting a clinic.
Founders & leadership
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$235M disclosed across 4 rounds · 2015–2022
▶$108.6MraisedMar 2022 · 45 investors · Other Health CareRule 506(b)
- Scott E. MendelDirector
- Mark IbisonExecutive Officer
- Jerome BeharDirector
- Thomas M. PrescottDirector
- Adam de la ZerdaExecutive Officer, Director
- Terri BresenhamDirector
- Eric MoessingerDirector
- John KuoExecutive Officer
- Amit ShahDirector
- Shlomo MelmedDirector
- Offering amount
- $156.4M
- Amount sold
- $108.6M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$100.8MraisedMay 2019 · 101 investors · Other TechnologyRule 506(b)
- Gregory LoneyExecutive Officer
- JEROME BEHARDirector
- AJIT SINGHExecutive Officer, Director
- ADAM DE LA ZERDAExecutive Officer, Director
- David EngmanDirector
- Offering amount
- $133.6M
- Amount sold
- $100.8M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.5MraisedJan 2018 · 21 investors · Other TechnologyRule 506(b)
- ADAM DE LA ZERDAExecutive Officer, Director
- AJIT SINGHExecutive Officer, Director
- JEROME BEHARDirector
- STEVEN ROSSTONDirector
- Offering amount
- $15M
- Amount sold
- $9.5M
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16MraisedNov 2015 · 30 investors · BiotechnologyRule 506(b)
- AJIT SINGHExecutive Officer, Director
- JEROME BEHARDirector
- ADAM DE LA ZERDADirector, Promoter
- STEVEN ROSSTONDirector
- Offering amount
- $16M
- Amount sold
- $16M
- First sale
- Oct 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $1.4M |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Click Diagnostics do?
- Click Diagnostics offers the Visby device, an at-home PCR test that delivers results in about 30 minutes for common curable STIs including chlamydia, gonorrhea, and trichomoniasis. It connects users with licensed providers who can prescribe treatment upon a positive result, aimed at consumers managing their sexual health without visiting a clinic.
- Who are Click Diagnostics's investors?
- Click Diagnostics's investors include Jam Fund.
- How much funding has Click Diagnostics raised?
- Click Diagnostics has disclosed $235M raised across 4 rounds.
- Where is Click Diagnostics headquartered?
- Click Diagnostics is headquartered in Menlo Park, US.
